Frontiers in Pharmacology (Dec 2020)

Anti-Inflammatory Effect of Geniposide on Regulating the Functions of Rheumatoid Arthritis Synovial Fibroblasts via Inhibiting Sphingosine-1-Phosphate Receptors1/3 Coupling Gαi/Gαs Conversion

  • Rong-hui Wang,
  • Rong-hui Wang,
  • Rong-hui Wang,
  • Rong-hui Wang,
  • Xue-jing Dai,
  • Xue-jing Dai,
  • Xue-jing Dai,
  • Xue-jing Dai,
  • Hong Wu,
  • Hong Wu,
  • Hong Wu,
  • Hong Wu,
  • Meng-die Wang,
  • Meng-die Wang,
  • Meng-die Wang,
  • Meng-die Wang,
  • Ran Deng,
  • Ran Deng,
  • Ran Deng,
  • Ran Deng,
  • Yan Wang,
  • Yan Wang,
  • Yan Wang,
  • Yan Wang,
  • Yan-hong Bu,
  • Yan-hong Bu,
  • Yan-hong Bu,
  • Yan-hong Bu,
  • Ming-hui Sun,
  • Ming-hui Sun,
  • Ming-hui Sun,
  • Ming-hui Sun,
  • Heng Zhang,
  • Heng Zhang,
  • Heng Zhang,
  • Heng Zhang

DOI
https://doi.org/10.3389/fphar.2020.584176
Journal volume & issue
Vol. 11

Abstract

Read online

The activated Gα protein subunit (Gαs) and the inhibitory Gα protein subunit (Gαi) are involved in the signal transduction of G protein coupled receptors (GPCRs). Moreover, the conversion of Gαi/Gαs can couple with sphingosine-1-phosphate receptors (S1PRs) and have a critical role in rheumatoid arthritis (RA). Through binding to S1PRs, sphingosine-1-phosphate (S1P) leads to activation of the pro-inflammatory signaling in rheumatoid arthritis synovial fibroblasts (RASFs). Geniposide (GE) can alleviate RASFs dysfunctions to against RA. However, its underlying mechanism of action in RA has not been elucidated so far. This study aimed to investigate whether GE could regulate the biological functions of MH7A cells by inhibiting S1PR1/3 coupling Gαi/Gαs conversion. We use RASFs cell line, namely MH7A cells, which were obtained from the patient with RA and considered to be the main effector cells in RA. The cells were stimulated with S1P (5 μmol/L) and then were treated with or without different inhibitors: Gαi inhibitor pertussis toxin (0.1 μg/mL), S1PR1/3 inhibitor VPC 23019 (5 μmol/L), Gαs activator cholera toxin (1 μg/mL) and GE (25, 50, and 100 μmol/L) for 24 h. The results showed that GE may inhibit the abnormal proliferation, migration and invasion by inhibiting the S1P-S1PR1/3 signaling pathway and activating Gαs or inhibiting Gαi protein in MH7A cells. Additionally, GE could inhibit the release of inflammatory factors and suppress the expression of cAMP, which is the key factor of the conversion of Gαi and Gαs. GE could also restore the dynamic balance of Gαi and Gαs by suppressing S1PR1/3 and inhibiting Gαi/Gαs conversion, in a manner, we demonstrated that GE inhibited the activation of Gα downstream ERK protein as well. Taken together, our results indicated that down-regulation of S1PR1/3-Gαi/Gαs conversion may play a critical role in the effects of GE on RA and GE could be an effective therapeutic agent for RA.

Keywords